{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:29:41Z","timestamp":1785292181963,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19KK0212"],"award-info":[{"award-number":["19KK0212"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22KK0123"],"award-info":[{"award-number":["22KK0123"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20\\u202FK08043"],"award-info":[{"award-number":["20\\u202FK08043"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJFS2102"],"award-info":[{"award-number":["JPMJFS2102"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2114"],"award-info":[{"award-number":["JPMJSP2114"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.nucmedbio.2024.108986","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T02:30:10Z","timestamp":1733106610000},"page":"108986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus"],"prefix":"10.1016","volume":"142-143","author":[{"given":"Yuka","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8538-8814","authenticated-orcid":false,"given":"Ryuichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaede","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitsuka","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-3079","authenticated-orcid":false,"given":"Shozo","family":"Furumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2024.108986_bb0005","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","article-title":"Biomarker-based staging of Alzheimer disease: rationale and clinical applications","volume":"20","author":"Therriault","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0015","article-title":"CenTauR: toward a universal scale and masks for standardizing tau imaging studies","volume":"15","author":"Villemagne","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0020","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2967\/jnumed.122.264434","article-title":"The Association of age-Related and off-Target Retention with longitudinal quantification of [(18)F]MK6240 tau PET in target regions","volume":"64","author":"Tissot","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","article-title":"Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43","volume":"605","author":"Jiang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","article-title":"Age-dependent formation of TMEM106B amyloid filaments in human brains","volume":"605","author":"Schweighauser","year":"2022","journal-title":"Nature"},{"issue":"1346\u201355","key":"10.1016\/j.nucmedbio.2024.108986_bb0040","article-title":"Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases","volume":"185","author":"Chang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41422-022-00665-3","article-title":"Generic amyloid fibrillation of TMEM106B in patient with Parkinson\u2019s disease dementia and normal elders","volume":"32","author":"Fan","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00401-022-02531-3","article-title":"Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging","volume":"145","author":"Perneel","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-024-01813-z","article-title":"Cleaved TMEM106B forms amyloid aggregates in central and peripheral nervous systems","volume":"12","author":"Bacioglu","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11307-013-0667-2","article-title":"Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer\u2019s disease brain","volume":"16","author":"Harada","year":"2014","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0065","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2967\/jnumed.123.265593","article-title":"Preclinical characterization of the tau PET tracer [(18)F]SNFT-1: comparison of tau PET tracers","volume":"64","author":"Harada","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41421-024-00674-z","article-title":"A tau PET tracer PBB3 binds to TMEM106B amyloid fibril in brain","volume":"10","author":"Zhao","year":"2024","journal-title":"Cell Discov"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0075","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3233\/JAD-170840","article-title":"18F-Flortaucipir binding in choroid plexus: related to race and Hippocampus signal","volume":"62","author":"Lee","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"42\u201358","key":"10.1016\/j.nucmedbio.2024.108986_bb0080","article-title":"High-contrast in vivo imaging of tau pathologies in Alzheimer\u2019s and non-Alzheimer\u2019s disease Tauopathies","volume":"109","author":"Tagai","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.apradiso.2017.04.021","article-title":"Minimization of the amount of Kryptofix 222 - KHCO(3) for applications to microscale (18)F-radiolabeling","volume":"125","author":"Iwata","year":"2017","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0006-8993(99)01466-3","article-title":"Biondi ring tangles in the choroid plexus of Alzheimer\u2019s disease and normal aging brains: a quantitative study","volume":"832","author":"Wen","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00401-013-1089-6","article-title":"Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid","volume":"125","author":"Bigio","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0100","doi-asserted-by":"crossref","first-page":"fcab190","DOI":"10.1093\/braincomms\/fcab190","article-title":"Evaluation of [(18)F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies","volume":"3","author":"Tezuka","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410150302","article-title":"A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography","volume":"15","author":"Mintun","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0110","doi-asserted-by":"crossref","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","article-title":"Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer\u2019s disease brain but not in transgenic mouse brain","volume":"25","author":"Klunk","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0120","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2967\/jnumed.118.224113","article-title":"Effect of off-target binding on (18)F-Flortaucipir variability in healthy controls across the life span","volume":"60","author":"Baker","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.27271","article-title":"The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases","volume":"33","author":"Vermeiren","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","article-title":"An autoradiographic evaluation of AV-1451 tau PET in dementia","volume":"4","author":"Lowe","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.24706","article-title":"[F-18]AV-1451 positron emission tomography retention in choroid plexus: more than \u201coff-target\u201d binding","volume":"80","author":"Ikonomovic","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40478-017-0482-0","article-title":"Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson\u2019s case","volume":"5","author":"Marquie","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0145","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1007\/s00259-022-05822-9","article-title":"Monoamine oxidase binding not expected to significantly affect [(18)F]flortaucipir PET interpretation","volume":"49","author":"Wright","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0150","doi-asserted-by":"crossref","first-page":"fcae075","DOI":"10.1093\/braincomms\/fcae075","article-title":"In vivo PET classification of tau pathologies in patients with frontotemporal dementia","volume":"6","author":"Kubota","year":"2024","journal-title":"Brain Commun"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0155","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","article-title":"18F-flortaucipir PET to autopsy comparisons in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"143","author":"Soleimani-Meigooni","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00401-023-02580-2","article-title":"Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology","volume":"146","author":"Neumann","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0170","doi-asserted-by":"crossref","first-page":"eadf9735","DOI":"10.1126\/scitranslmed.adf9735","article-title":"TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia","volume":"16","author":"Marks","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0175","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1093\/brain\/awad133","article-title":"C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes","volume":"146","author":"Vincente","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2024.108986_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00401-024-02807-w","article-title":"TMEM106B amyloid filaments in the Biondi bodies of ependymal cells","volume":"148","author":"Ghetti","year":"2024","journal-title":"Acta Neuropathol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124001124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124001124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:05:46Z","timestamp":1762347946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124001124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":36,"alternative-id":["S0969805124001124"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108986","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transmembrane protein 106B amyloid is a potential off-target molecule of tau PET tracers in the choroid plexus","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108986"}}